Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Guggenheim Partners

Tracked across 41 events · 357 articles · First seen Mar 04, 2025 · Last active Sep 14, 2026

Sentiment
11
Attention
6
Events
41
Relationships
12
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: Guggenheim Partners acted as a lead book-running manager, earning fees and demonstrating its capability in executing biotech IPOs. The successful offering supports its investment banking business.
Aug 07, 2026 · 8 articles
2 40
Business
Impact: Acting as sole book-running manager, Guggenheim Partners facilitated the IPO and received an over-allotment option, generating underwriting fees and strengthening its role in the SPAC market.
Aug 25, 2026 · 7 articles
2 10
Business
Impact: Guggenheim Partners acted as the sole book-running manager for the IPO of BHAV Acquisition Corp, facilitating the offering and demonstrating its role in capital markets.
Apr 16, 2026 · 6 articles
4 0
Business
Impact: Guggenheim Partners is acting as a book-running manager for the public offering by Forte Biosciences.
Apr 08, 2026 · 7 articles
4 10
Business
Impact: Guggenheim Partners is acting as a joint book-running manager for the public offering of Spyre Therapeutics' common stock.
Apr 13, 2026 · 7 articles
2 20
Business
Impact: Guggenheim analyst John DiFucci upgraded ServiceNow from Neutral to Buy, a valuation-driven call that contributed to a 6.8% stock jump.
Jun 26, 2026 · 6 articles
2 10
Business
Impact: Guggenheim Partners is the sole book-running manager for the offering, earning underwriting fees and strengthening its relationship with Edesa.
Aug 19, 2026 · 12 articles
2 20
Business
Impact: Guggenheim Partners served as joint bookrunning manager, participating in the offering and earning fees. The deal contributes to its investment banking activity in the biotech sector.
Jul 20, 2026 · 22 articles
4 10
Regulatory
Impact: Guggenheim Partners analysts published a report exposing the limited experience and resources of ENTRA1 Energy LLC, contributing to the stock drop of NuScale Power.
Feb 19, 2026 · 26 articles
4 10
Business
Impact: Guggenheim Partners is acting as a book-running manager for the public offering by Sophia Genetics.
Jun 16, 2026 · 7 articles
2 5
Business
Impact: Guggenheim Partners is a joint book-running manager, participating in the offering and earning fees.
Aug 04, 2026 · 6 articles
6 60
Business
Impact: Guggenheim Partners' Executive Chairman, Alan Schwartz, participated in a fireside chat with Ahmed Jasim Al Zaabi at the Milken Institute Global Conference, discussing global financial innovation.
May 13, 2026 · 8 articles
4 0
Business
Impact: Guggenheim Partners is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
4 10
Business
Impact: Guggenheim Partners is acting as an active book-running manager for the initial public offering of Parabilis Medicines.
Jun 10, 2026 · 7 articles
4 15
Business
Impact: Guggenheim Securities is a co-global coordinator and joint bookrunner, involved in the IPO.
Jul 20, 2026 · 6 articles
4 60
Business
Impact: Guggenheim Partners acted as a joint book-running manager, earning underwriting fees.
Jul 06, 2026 · 25 articles
4 0
Business
Impact: Guggenheim Partners acted as a bookrunner for the offering.
Apr 06, 2026 · 8 articles
4 10
Business
Impact: Guggenheim Securities is acting as a bookrunner for Eric Rock's IPO.
Jun 01, 2026 · 7 articles
2 5
Business
Impact: Guggenheim Securities acted as joint book-running manager for the offering, earning underwriting fees.
Jul 14, 2026 · 7 articles
2 5
Business
Altor BioScience, Inc. (Nasdaq: YARW), a clinical-stage biotechnology company focused on developing therapies for autoimmune thyroid diseases, commenced and then priced an underwritten public offering of 5,769,231 shares of its common stock at $26.00 per…
Impact: Guggenheim Partners served as a joint book-running manager for Altor BioScience's public offering, earning underwriting fees.
Sep 10, 2026 · 7 articles
4 0
Regulatory
Impact: Guggenheim Partners was engaged by Sleep Number Corporation to evaluate strategic and financing options, which was cited as a reason for suspending financial guidance.
May 19, 2026 · 6 articles
4 0
Business
Impact: Guggenheim Securities served as exclusive financial advisor to Forte Biosciences.
Jul 27, 2026 · 6 articles
2 30
Business
Impact: Guggenheim raised its price target to $300, citing strong revenue growth expectations and early adoption of Bits AI.
Jul 17, 2026 · 7 articles
2 0
Business
Impact: Acted as financial advisor to Maverick in the transaction.
Aug 03, 2026 · 6 articles
2 20
Business
Impact: Guggenheim Partners initiated coverage with a Buy rating and a $180 price target, highlighting Guidewire's strong position in the P&C insurance sector.
Jul 14, 2026 · 6 articles
2 0
Business
Impact: Guggenheim Partners acts as a joint bookrunner, earning underwriting fees.
Aug 13, 2026 · 6 articles
6 0
Business
General Electric — GE Aerospace agreed on September 8, 2026 to acquire Consolidated Precision Products (CPP), a leading manufacturer of investment and precision sand castings for aerospace, defense, and power generation, from private equity firms…
Impact: Financial advisor to CPP.
Sep 08, 2026 · 23 articles
1 10
Business
Guidewire Software CEO Michael Rosenbaum sold 1,200 shares of company stock on two occasions in August 2026, according to SEC Form 4 filings. The first sale occurred on August 17, 2026, at a weighted average…
Impact: Raised price target to $210 and initiated coverage with a buy rating, expressing confidence in Guidewire's estimates.
Aug 24, 2026 · 7 articles
4 5
Business
Impact: Guggenheim Securities is a joint lead book-running manager for the offering.
Apr 20, 2026 · 7 articles
3 5
Business
Impact: Guggenheim Securities acted as additional bookrunning manager, earning underwriting fees.
Jul 20, 2026 · 19 articles
+ 11 more events View on Dashboard
Leerink Partners ↔ Guggenheim Partners
Leerink Partners ↔ Guggenheim Partners
Wells Fargo ↔ Guggenheim Partners
Wells Fargo ↔ Guggenheim Partners
JPMorgan Chase ↔ Guggenheim Partners
JPMorgan Chase ↔ Guggenheim Partners
Goldman Sachs ↔ Guggenheim Partners
Goldman Sachs ↔ Guggenheim Partners
Nasdaq ↔ Guggenheim Partners
Nasdaq ↔ Guggenheim Partners
ERGEN INTELLIGENCE
Track Guggenheim Partners live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.